Brain Tumor Research and Treatment

The Korean Brain Tumor Society (대한뇌종양학회)
권호 표지
DOI QR코드

DOI QR Code

Giant Sellar Xanthogranuloma after Surgical Treatment of Symptomatic Rathke's Cleft Cyst

  • Cho, Sung-Min (Department of Neurosurgery, Kosin University Gospel Hospital) ;
  • Cho, Hyok-Rae (Department of Neurosurgery, Kosin University Gospel Hospital) ;
  • Park, Yong-Seok (Department of Neurosurgery, Kosin University Gospel Hospital) ;
  • Chang, Hee-Gyeong (Department of Pathology, Kosin University Gospel Hospital)
  • Received : 2018.04.23
  • Accepted : 2018.09.18
  • Published : 2018.10.31
⟨ Previous Next ⟩

Abstract

Extremely massive sellar xanthogranuloma (XG) are rare, and the surgical outcome and prognosis are not well known. XG remain unknown whether they are derived from Rathke's cleft cysts (RCCs) or craniopharyngiomas (CPs) following extensive inflammation and metaplasia, to the point that no epithelium is readily identifiable. These lesions usually tend to occur in younger patients (mean 28.3 years), have a smaller diameter, and remain primarily intrasellar region with infrequent calcification. This 36-year-old man presented our hospital with visual deterioration. At the time of visit, there were no neurological problems other than visual field defect and hormonal disorder. He visited our hospital in 2007 due to headache and decreased vision, and underwent transphenoid surgery for pituitary RCC. Since then, he has received treatment at our hospital for postoperative hormonal disorders. Through preoperative imaging study, the author suspected CP and underwent surgery. During the operation, the adhesion of the tumor to the surrounding major neurovascular structures was severe in the naked eyes, but the tumor could be removed more easily than expected. The postoperative histological findings were confirmed as XG. The postoperative course was uneventful. Compared to the previous literature, this case is a case where the size of XG is very large in a sellar region and it can be proved that it originated from the RCC. And regular follow-up is necessary to confirm the prognosis after surgery.

Keywords

References

  1. Rahmani R, Sukumaran M, Donaldson AM, Akselrod O, Lavi E, Schwartz TH. Parasellar xanthogranulomas. J Neurosurg 2015;122:812-7. https://doi.org/10.3171/2014.12.JNS14542
  2. Liu ZH, Tzaan WC, Wu YY, Chen HC. Sellar xanthogranuloma manifesting as obstructive hydrocephalus. J Clin Neurosci 2008;15:929-33. https://doi.org/10.1016/j.jocn.2007.05.028
  3. Kamoshima Y, Sawamura Y, Motegi H, Kubota K, Houkin K. Xanthogranuloma of the sellar region of children: series of five cases and literature review. Neurol Med Chir (Tokyo) 2011;51:689-93. https://doi.org/10.2176/nmc.51.689
  4. Nishiuchi T, Murao K, Imachi H, et al. Xanthogranuloma of the intrasellar region presenting in pituitary dysfunction: a case report. J Med Case Rep 2012;6:119. https://doi.org/10.1186/1752-1947-6-119
  5. Hernandez-Estrada RA, Kshettry VR, Vogel AN, Curtis MT, Evans JJ. Cholesterol granulomas presenting as sellar masses: a similar, but clinically distinct entity from craniopharyngioma and Rathke's cleft cyst. Pituitary 2017;20:325-32. https://doi.org/10.1007/s11102-016-0775-5
  6. Yang B, Yang C, Fang J, et al. Clinicoradiologic features and surgical outcomes of sellar xanthogranulomas: a single-center 10-year experience. World Neurosurg 2017;99:439-47. https://doi.org/10.1016/j.wneu.2016.12.017
  7. Dai CX, Guo XS, Liu XH, et al. Xanthogranuloma of the sellar region. Chin Med J (Engl) 2017;130:249-50.
  8. Paulus W, Honegger J, Keyvani K, Fahlbusch R. Xanthogranuloma of the sellar region: a clinicopathological entity different from adamantinomatous craniopharyngioma. Acta Neuropathol 1999;97:377-82. https://doi.org/10.1007/s004010051001
  9. Amano K, Kubo O, Komori T, et al. Clinicopathological features of sellar region xanthogranuloma: correlation with Rathke's cleft cyst. Brain Tumor Pathol 2013;30:233-41. https://doi.org/10.1007/s10014-012-0130-0
  10. Miyajima Y, Oka H, Utsuki S, Fujii K. Rathke's cleft cyst with xanthogranulomatous change--case report. Neurol Med Chir (Tokyo) 2011;51:740-2. https://doi.org/10.2176/nmc.51.740
  11. Hama S, Arita K, Nishisaka T, et al. Changes in the epithelium of Rathke cleft cyst associated with inflammation. J Neurosurg 2002;96:209-16. https://doi.org/10.3171/jns.2002.96.2.0209
  12. Le BH, Towfighi J, Kapadia SB, Lopes MB. Comparative immunohistochemical assessment of craniopharyngioma and related lesions. Endocr Pathol 2007;18:23-30. https://doi.org/10.1007/s12022-007-0011-y
  13. Arai A, Nishihara M, Sasayama T, et al. Xanthogranuloma of the sellar region--case report. Neurol Med Chir (Tokyo) 2010;50:488-91. https://doi.org/10.2176/nmc.50.488
  14. Jung CS, Schanzer A, Hattingen E, Plate KH, Seifert V. Xanthogranuloma of the sellar region. Acta Neurochir (Wien) 2006;148:473-7. https://doi.org/10.1007/s00701-005-0700-6
  15. Sugata S, Hirano H, Yatsushiro K, Yunoue S, Nakamura K, Arita K. Xanthogranuloma in the suprasellar region. Neurol Med Chir (Tokyo) 2009;49:124-7. https://doi.org/10.2176/nmc.49.124
  16. Hofmann BM, Kreutzer J, Saeger W, et al. Nuclear beta-catenin accumulation as reliable marker for the differentiation between cystic craniopharyngiomas and rathke cleft cysts: a clinico-pathologic approach. Am J Surg Pathol 2006;30:1595-603. https://doi.org/10.1097/01.pas.0000213328.64121.12
  17. Buslei R, Nolde M, Hofmann B, et al. Common mutations of betacatenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol 2005;109:589-97. https://doi.org/10.1007/s00401-005-1004-x